Use of anti-androgenic 5α-reductase inhibitors and risk of oesophageal and gastric cancer by histological type and anatomical sub-site

BACKGROUND: To investigate if anti-androgenic medications 5α-reductase inhibitors (5-ARIs) decrease the risk of developing oesophageal and gastric tumours, analysed by histological type and anatomical sub-site. METHODS: A Swedish population-based cohort study between 2005 and 2018 where men using 5-...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabbani, Sirus, Santoni, Giola, Lagergren, Jesper, Xie, Shao-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427733/
https://www.ncbi.nlm.nih.gov/pubmed/35715630
http://dx.doi.org/10.1038/s41416-022-01872-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427733/
https://www.ncbi.nlm.nih.gov/pubmed/35715630
http://dx.doi.org/10.1038/s41416-022-01872-w

Ejemplares similares